Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor.
about
Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase.Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathwayViral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.The IRF family, revisitedThe crystal structure of the DNA-binding domain of vIRF-1 from the oncogenic KSHV reveals a conserved fold for DNA binding and reinforces its role as a transcription factorMolecular virology of Kaposi's sarcoma-associated herpesvirusKaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin?Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45.Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300.Newly emerging therapies targeting viral-related lymphomas.KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3.Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis.Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseasesInhibition of p300 histone acetyltransferase by viral interferon regulatory factor.Evolutionary aspects of oncogenic herpesvirusesAltered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirusSuppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transductionInhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1.Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivatorImmune evasion by Kaposi's sarcoma-associated herpesvirus.Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesisKaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesisThree unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors.Viral interferon regulatory factors decrease the induction of type I and type II interferon during rhesus macaque rhadinovirus infection.The viral interferon regulatory factors of KSHV: immunosuppressors or oncogenes?Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes.Warts and all: human papillomavirus in primary immunodeficiencies.AIDS-associated Kaposi's sarcoma: is there still a role for interferon alfa?Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent declinViral Interferon Regulatory Factor 1 of Kaposi's Sarcoma-Associated Herpesvirus Interacts with a Translocation Liposarcoma Protein-Associated Serine-Arginine Protein.Viral interferon regulatory factors.Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency.Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview.Innate antiviral response: role in HIV-1 infection.
P2860
Q24290751-C51CE6CE-C7A9-4D4C-80E2-FB9EABAABAC5Q24316207-4CB8BA87-F733-4493-AD79-E5EA2E95E2A1Q24538223-DF37ECE1-BE00-4151-83AF-2607D4FDB023Q24678497-16C4DE5D-0650-485F-A9CB-B3AC38BBDC33Q27676606-B7D35990-DCFB-4E25-83C4-D7A3E9886A5EQ28363323-AF65CEBB-A625-4B6B-ACB0-903E0DC01C8AQ29394711-12407AF1-415C-4D21-91F5-2C451FFA8702Q30840864-43D5C9F7-6011-416C-83A0-360ACD6FAB30Q33560572-51FA7B26-2450-4AC7-BEB7-832B25277497Q33582093-FE3E9937-ACAC-4887-982B-75987B90CC44Q33649357-37C42F39-3BF8-43BB-BD84-FF7DF45A35C5Q33699201-9254C424-32A0-4DDA-BCB0-F0B0130A2B0BQ33761091-9765B1DF-1B93-44AF-B553-7CEBAB15E098Q33781480-47536461-0FA5-4941-B6DC-ED71444F375BQ33834993-20CBA3D8-F10A-45FB-AE63-118219868C9FQ33842636-191F9A24-14AF-46C1-8A77-18AA5BF0D5A9Q33906970-C401666B-AF97-4FCA-9FF6-2D693065E1C1Q33966269-F122853C-0789-47DD-8D79-7C609A9E8179Q34089478-06CB87BD-4108-4D33-973F-F35500D3CD56Q34333300-8AD3E874-3CAC-41DE-BB74-DC8D092BF6B5Q34359241-9DCF92DB-1B92-4FAF-8BF3-7D5D2ABD2682Q34434681-5E458795-A1C1-44C0-8C38-57D7B8A69ECDQ34615002-458E7EAB-E4B2-4B9D-8E95-70C69DB9211EQ34782463-58C8228B-5E3B-437D-B521-073626948639Q34795543-DCF8CFA3-8AEB-4E61-960D-8266CA86F794Q35026060-3DDC2722-C4EE-4043-8235-63F85060EBA1Q35124404-B3D1762D-42EE-43AD-828A-C9C75D9BCF7CQ35127940-7050D40F-C8B9-4B0F-8296-67A6766ADEF2Q35656534-D4FA6689-DD8B-4AEF-A59D-8C5BE411941BQ35826613-0AB2ED02-AC97-48AF-8119-B635A53A4C28Q35927496-9B268F99-919A-4830-A637-19F843D3D309Q35964857-79B887AC-177F-4963-A229-4DCB6B8864DCQ36455030-19656828-3982-4150-918A-DB5A9803C220Q36893107-6FDA0853-4E85-4289-8EC3-FD45DF1A5E19Q37010247-55BC16B2-1440-41E9-B350-0925E2EC5251Q37083091-5BA379CE-E10B-4496-88D8-814E931B1315Q37588733-5FB0AD20-4DDE-4B79-817D-BE4F28F55223Q37683398-9737514C-AE89-4AA4-82BD-ACA6D136FA5AQ37903168-20B8827B-7811-405C-BE67-EB4DF41D0B93Q37945237-0B0B4A24-F5B8-44AF-BCDE-6316DCDF5812
P2860
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor.
@ast
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor.
@en
type
label
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor.
@ast
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor.
@en
prefLabel
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor.
@ast
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor.
@en
P2093
P2860
P1433
P1476
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor.
@en
P2093
B Fleckenstein
P2860
P304
P577
1998-07-01T00:00:00Z